Timod, Letleth B.
HRN: 24-79-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2024
CO-AMOXICLAV 625MG (TAB)
04/12/2024
04/18/2024
PO
1 Tab
BID
SP NSVD With 2nd RMLE And Repair
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes